Cargando…
HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia
SIMPLE SUMMARY: Hypoxia is one of the characteristics of most solid tumors and induces cell resistant to chemotherapy. In this paper, we established a hypoxia model in both in vitro and in vivo to investigate the mechanisms of Sorafenib resistance in Hepatocellular carcinoma (HCC). Here, we observed...
Autores principales: | Liao, Yan, Yang, Yue, Pan, Di, Ding, Youxiang, Zhang, Heng, Ye, Yuting, Li, Jia, Zhao, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827218/ https://www.ncbi.nlm.nih.gov/pubmed/33440739 http://dx.doi.org/10.3390/cancers13020243 |
Ejemplares similares
-
The Role of HSP90α in Methamphetamine/Hyperthermia-Induced Necroptosis in Rat Striatal Neurons
por: Liao, Lv-shuang, et al.
Publicado: (2021) -
Hsp90 modulates the stability of MLKL and is required for TNF-induced necroptosis
por: Zhao, X M, et al.
Publicado: (2016) -
HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma
por: Liao, Yuning, et al.
Publicado: (2023) -
Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma
por: Wei, Wene, et al.
Publicado: (2020) -
The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)